Literature DB >> 32508308

Considerations for cancer immunotherapy biomarker research during COVID-19.

Jennifer W Carlisle1,2, Caroline S Jansen1,3,4, Mehmet Asim Bilen1,2, Haydn Kissick1,3,5,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32508308      PMCID： PMC7385701          DOI： 10.1530/ERC-20-0187

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  59 in total

1.  Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.

Authors:  S Chandrashekara; Masoodi Mukhtar Ahmad; Panchagnula Renuka; K R Anupama; K Renuka
Journal:  Int J Rheum Dis       Date:  2017-09-26       Impact factor: 2.454

2.  Cytokine release syndrome in severe COVID-19.

Authors:  John B Moore; Carl H June
Journal:  Science       Date:  2020-04-17       Impact factor: 47.728

3.  Between Scylla and Charybdis - Oncologic Decision Making in the Time of Covid-19.

Authors:  Mark A Lewis
Journal:  N Engl J Med       Date:  2020-04-07       Impact factor: 91.245

4.  T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.

Authors:  Alexander C Huang; Michael A Postow; Robert J Orlowski; Rosemarie Mick; Bertram Bengsch; Sasikanth Manne; Wei Xu; Shannon Harmon; Josephine R Giles; Brandon Wenz; Matthew Adamow; Deborah Kuk; Katherine S Panageas; Cristina Carrera; Phillip Wong; Felix Quagliarello; Bradley Wubbenhorst; Kurt D'Andrea; Kristen E Pauken; Ramin S Herati; Ryan P Staupe; Jason M Schenkel; Suzanne McGettigan; Shawn Kothari; Sangeeth M George; Robert H Vonderheide; Ravi K Amaravadi; Giorgos C Karakousis; Lynn M Schuchter; Xiaowei Xu; Katherine L Nathanson; Jedd D Wolchok; Tara C Gangadhar; E John Wherry
Journal:  Nature       Date:  2017-04-10       Impact factor: 49.962

5.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.

Authors:  Joseph D Miller; Robbert G van der Most; Rama S Akondy; John T Glidewell; Sophia Albott; David Masopust; Kaja Murali-Krishna; Patryce L Mahar; Srilatha Edupuganti; Susan Lalor; Stephanie Germon; Carlos Del Rio; Mark J Mulligan; Silvija I Staprans; John D Altman; Mark B Feinberg; Rafi Ahmed
Journal:  Immunity       Date:  2008-05-08       Impact factor: 31.745

6.  Acute-phase proteins: As diagnostic tool.

Authors:  Sachin Jain; Vidhi Gautam; Sania Naseem
Journal:  J Pharm Bioallied Sci       Date:  2011-01

7.  Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.

Authors:  Kristine H Allin; Børge G Nordestgaard; Henrik Flyger; Stig E Bojesen
Journal:  Breast Cancer Res       Date:  2011-06-03       Impact factor: 6.466

8.  The role of interleukin-6 in monitoring severe case of coronavirus disease 2019.

Authors:  Tao Liu; Jieying Zhang; Yuhui Yang; Hong Ma; Zhenyu Li; Jiaoyue Zhang; Ji Cheng; Xiaoyun Zhang; Yanxia Zhao; Zihan Xia; Liling Zhang; Gang Wu; Jianhua Yi
Journal:  EMBO Mol Med       Date:  2020-06-05       Impact factor: 12.137

9.  High-Sensitivity C-Reactive Protein: A Potential Ancillary Biomarker for Malaria Diagnosis and Morbidity.

Authors:  Otchere Addai-Mensah; Max Efui Annani-Akollor; Linda Ahenkorah Fondjo; Enoch Odame Anto; Daniel Gyamfi; Lorraine Sallah; Dennis Agama; Richard Djabatey; Eddie-Williams Owiredu
Journal:  Dis Markers       Date:  2019-04-04       Impact factor: 3.434

10.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

Authors:  Qiurong Ruan; Kun Yang; Wenxia Wang; Lingyu Jiang; Jianxin Song
Journal:  Intensive Care Med       Date:  2020-03-03       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.